Japan: From Discovery to Clinical Utility - Thinking Plasma Biomarkers for Alzheimer’s Disease End-to-End

*This is a Japanese video. You can find English videos here.

Genedata presented the following talk at the webinar “Danaher Group Solutions & Case Studies Supporting Biomarker Discovery and Evaluation in Drug Discovery” co-hosted with Leica Microsystems, Abcam, and Molecular Devices.

From Discovery to Clinical Utility: Thinking Plasma Biomarkers for Alzheimer’s Disease End-to-End
Shunya Kondo, Ph.D., Scientific Business Consultant, Genedata AG

Translating biomarker discoveries into clinically reliable and scalable blood-based diagnostics for Alzheimer’s disease remains challenging. In this webinar, we present an end‑to‑end Alzheimer’s biomarker program facilitating this process. We demonstrate how proteomic profiling can complement established markers, and how an integrated, governed data and analytics approach enables multi‑modal analysis, cross‑disciplinary collaboration, and smoother transitions from discovery to diagnostic translation.